Byrne Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
AIM
CWP
DADC
WG
Byrne Asset Management's PFE Position: Q2 2026 in Review
Byrne Asset Management reduced its Pfizer (PFE) stake by 9.6% in Q2 2026, selling an estimated $74.9K and leaving 26,848 shares worth $647K. The position accounts for 0.35% of the portfolio, ranked #70.
Byrne Asset Management first reported a position in PFE in Q4 2021 and has held it in 15 quarters since. The position peaked at $2.39M in Q4 2021. 900 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Byrne Asset Management held 26,848 shares of Pfizer worth $647K as of Q2 2026.
- Byrne Asset Management sold 2,863 Pfizer shares in Q2 2026, an estimated $74.9K.
- Pfizer made up 0.35% of Byrne Asset Management's portfolio in Q2 2026, its #70 holding.
- Byrne Asset Management first reported a position in Pfizer in Q4 2021 and has held it in 15 quarters since.
- Byrne Asset Management's Pfizer position peaked at $2.39M in Q4 2021.
- 900 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Byrne Asset Management's 13F filing for Q2 2026, filed 7 Jul 2026.